APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Endocrine Therapy Drugs (ETDs)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Endocrine Therapy Drugs (ETDs) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026182 pages

Choose your research edition.

Industry ResearchEndocrine Therapy Drugs (ETDs) Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Endocrine Therapy Drugs (ETDs) Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Endocrine Therapy Drugs (ETDs) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Endocrine Therapy Drugs (ETDs) Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Endocrine Therapy Drugs (ETDs) Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Endocrine Therapy Drugs (ETDs) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Endocrine Therapy Drugs (ETDs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Endocrine Therapy Drugs (ETDs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Endocrine Therapy Drugs (ETDs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Endocrine Therapy Drugs (ETDs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Endocrine Therapy Drugs (ETDs) include Sanofi, Pfizer, Bayer, AstraZeneca, Tonghua Dongbao Pharmaceutical, Novo Nordisk, MSD, Huadong Medicine and Generex Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Endocrine Therapy Drugs (ETDs) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Endocrine Therapy Drugs (ETDs) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Endocrine Therapy Drugs (ETDs) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Endocrine Therapy Drugs (ETDs) market size, projected growth trends, production technologies, key applications, and end-use industries.

Endocrine Therapy Drugs (ETDs) Segment by Company

Sanofi

Pfizer

Bayer

AstraZeneca

Tonghua Dongbao Pharmaceutical

Novo Nordisk

MSD

Huadong Medicine

Generex Biotechnology

Endocrine Therapy Drugs (ETDs) Segment by Type

Antidiabetic Drugs

Anti-osteoporosis Drugs

Contraceptive

Other

Endocrine Therapy Drugs (ETDs) Segment by Application

Diabetes Treatment

Osteoporosis Treatment

Contraception

Other

Endocrine Therapy Drugs (ETDs) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endocrine Therapy Drugs (ETDs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Endocrine Therapy Drugs (ETDs) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endocrine Therapy Drugs (ETDs).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Endocrine Therapy Drugs (ETDs) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Endocrine Therapy Drugs (ETDs) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Endocrine Therapy Drugs (ETDs) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Endocrine Therapy Drugs (ETDs) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Endocrine Therapy Drugs (ETDs) Industry Trends Table 2. Endocrine Therapy Drugs (ETDs) Industry Drivers Table 3. Endocrine Therapy Drugs (ETDs) Industry Opportunities and Challenges Table 4. Endocrine Therapy Drugs (ETDs) Industry Restraints Table 5. Global Endocrine Therapy Drugs (ETDs) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Endocrine Therapy Drugs (ETDs) Sales by Manufacturers (Tons) & (2021-2026) Table 8. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Manufacturers Table 9. Global Endocrine Therapy Drugs (ETDs) Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Endocrine Therapy Drugs (ETDs) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Endocrine Therapy Drugs (ETDs) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Endocrine Therapy Drugs (ETDs) Manufacturers, Product Type & Application Table 13. Global Endocrine Therapy Drugs (ETDs) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Endocrine Therapy Drugs (ETDs) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Antidiabetic Drugs Table 17. Major Manufacturers of Anti-osteoporosis Drugs Table 18. Major Manufacturers of Contraceptive Table 19. Major Manufacturers of Other Table 20. Global Endocrine Therapy Drugs (ETDs) Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 21. Global Endocrine Therapy Drugs (ETDs) Sales by Type (2021-2026) & (Tons) Table 22. Global Endocrine Therapy Drugs (ETDs) Sales by Type (2027-2032) & (Tons) Table 23. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Type (2021-2026) Table 24. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Type (2027-2032) Table 25. Global Endocrine Therapy Drugs (ETDs) Revenue by Type 2021 VS 2025 VS 2032 (Tons) Table 26. Global Endocrine Therapy Drugs (ETDs) Revenue by Type (2021-2026) & (Tons) Table 27. Global Endocrine Therapy Drugs (ETDs) Revenue by Type (2027-2032) & (Tons) Table 28. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Type (2021-2026) Table 29. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Diabetes Treatment Table 31. Major Manufacturers of Osteoporosis Treatment Table 32. Major Manufacturers of Contraception Table 33. Major Manufacturers of Other Table 34. Global Endocrine Therapy Drugs (ETDs) Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 35. Global Endocrine Therapy Drugs (ETDs) Sales by Application (2021-2026) & (Tons) Table 36. Global Endocrine Therapy Drugs (ETDs) Sales by Application (2027-2032) & (Tons) Table 37. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Application (2021-2026) Table 38. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Application (2027-2032) Table 39. Global Endocrine Therapy Drugs (ETDs) Revenue by Application 2021 VS 2025 VS 2032 (Tons) Table 40. Global Endocrine Therapy Drugs (ETDs) Revenue by Application (2021-2026) & (Tons) Table 41. Global Endocrine Therapy Drugs (ETDs) Revenue by Application (2027-2032) & (Tons) Table 42. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Application (2021-2026) Table 43. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Application (2027-2032) Table 44. Global Endocrine Therapy Drugs (ETDs) Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 45. Global Endocrine Therapy Drugs (ETDs) Sales by Region (2021-2026) & (Tons) Table 46. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Region (2021-2026) Table 47. Global Endocrine Therapy Drugs (ETDs) Sales Forecasted by Region (2027-2032) & (Tons) Table 48. Global Endocrine Therapy Drugs (ETDs) Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Endocrine Therapy Drugs (ETDs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 50. North America Endocrine Therapy Drugs (ETDs) Sales by Country (2021-2026) & (Tons) Table 51. North America Endocrine Therapy Drugs (ETDs) Sales by Country (2027-2032) & (Tons) Table 52. Europe Endocrine Therapy Drugs (ETDs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 53. Europe Endocrine Therapy Drugs (ETDs) Sales by Country (2021-2026) & (Tons) Table 54. Europe Endocrine Therapy Drugs (ETDs) Sales by Country (2027-2032) & (Tons) Table 55. Asia Pacific Endocrine Therapy Drugs (ETDs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 56. Asia Pacific Endocrine Therapy Drugs (ETDs) Sales by Country (2021-2026) & (Tons) Table 57. Asia Pacific Endocrine Therapy Drugs (ETDs) Sales by Country (2027-2032) & (Tons) Table 58. South America, Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 59. South America, Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales by Country (2021-2026) & (Tons) Table 60. South America, Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales by Country (2027-2032) & (Tons) Table 61. Global Endocrine Therapy Drugs (ETDs) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Endocrine Therapy Drugs (ETDs) Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Endocrine Therapy Drugs (ETDs) Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Region (2021-2026) Table 65. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Region (2027-2032) Table 66. Sanofi Company Information Table 67. Sanofi Business Overview Table 68. Sanofi Endocrine Therapy Drugs (ETDs) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Sanofi Endocrine Therapy Drugs (ETDs) Product Portfolio Table 70. Sanofi Recent Development Table 71. Pfizer Company Information Table 72. Pfizer Business Overview Table 73. Pfizer Endocrine Therapy Drugs (ETDs) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Pfizer Endocrine Therapy Drugs (ETDs) Product Portfolio Table 75. Pfizer Recent Development Table 76. Bayer Company Information Table 77. Bayer Business Overview Table 78. Bayer Endocrine Therapy Drugs (ETDs) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Bayer Endocrine Therapy Drugs (ETDs) Product Portfolio Table 80. Bayer Recent Development Table 81. AstraZeneca Company Information Table 82. AstraZeneca Business Overview Table 83. AstraZeneca Endocrine Therapy Drugs (ETDs) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. AstraZeneca Endocrine Therapy Drugs (ETDs) Product Portfolio Table 85. AstraZeneca Recent Development Table 86. Tonghua Dongbao Pharmaceutical Company Information Table 87. Tonghua Dongbao Pharmaceutical Business Overview Table 88. Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Product Portfolio Table 90. Tonghua Dongbao Pharmaceutical Recent Development Table 91. Novo Nordisk Company Information Table 92. Novo Nordisk Business Overview Table 93. Novo Nordisk Endocrine Therapy Drugs (ETDs) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Novo Nordisk Endocrine Therapy Drugs (ETDs) Product Portfolio Table 95. Novo Nordisk Recent Development Table 96. MSD Company Information Table 97. MSD Business Overview Table 98. MSD Endocrine Therapy Drugs (ETDs) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. MSD Endocrine Therapy Drugs (ETDs) Product Portfolio Table 100. MSD Recent Development Table 101. Huadong Medicine Company Information Table 102. Huadong Medicine Business Overview Table 103. Huadong Medicine Endocrine Therapy Drugs (ETDs) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Huadong Medicine Endocrine Therapy Drugs (ETDs) Product Portfolio Table 105. Huadong Medicine Recent Development Table 106. Generex Biotechnology Company Information Table 107. Generex Biotechnology Business Overview Table 108. Generex Biotechnology Endocrine Therapy Drugs (ETDs) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Generex Biotechnology Endocrine Therapy Drugs (ETDs) Product Portfolio Table 110. Generex Biotechnology Recent Development Table 111. Key Raw Materials Table 112. Raw Materials Key Suppliers Table 113. Endocrine Therapy Drugs (ETDs) Distributors List Table 114. Endocrine Therapy Drugs (ETDs) Customers List Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Endocrine Therapy Drugs (ETDs) Product Image Figure 2. Global Endocrine Therapy Drugs (ETDs) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Endocrine Therapy Drugs (ETDs) Market Size (2021-2032) & (US$ Million) Figure 4. Global Endocrine Therapy Drugs (ETDs) Sales (2021-2032) & (Tons) Figure 5. Global Endocrine Therapy Drugs (ETDs) Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Endocrine Therapy Drugs (ETDs) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Antidiabetic Drugs Image Figure 9. Anti-osteoporosis Drugs Image Figure 10. Contraceptive Image Figure 11. Other Image Figure 12. Global Endocrine Therapy Drugs (ETDs) Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 13. Global Endocrine Therapy Drugs (ETDs) Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Type (2021-2032) Figure 15. Global Endocrine Therapy Drugs (ETDs) Revenue by Type (2021 VS 2025 VS 2032) & (Tons) Figure 16. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Type (2021-2032) Figure 18. Diabetes Treatment Image Figure 19. Osteoporosis Treatment Image Figure 20. Contraception Image Figure 21. Other Image Figure 22. Global Endocrine Therapy Drugs (ETDs) Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 23. Global Endocrine Therapy Drugs (ETDs) Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Application (2021-2032) Figure 25. Global Endocrine Therapy Drugs (ETDs) Revenue by Application (2021 VS 2025 VS 2032) & (Tons) Figure 26. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Application (2021-2032) Figure 28. North America Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2021-2032) & (Tons) Figure 29. North America Endocrine Therapy Drugs (ETDs) Sales Market Share by Country (2021-2032) Figure 30. U.S. Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2021-2032) & (Tons) Figure 31. Canada Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2021-2032) & (Tons) Figure 32. Mexico Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2021-2032) & (Tons) Figure 33. Europe Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2021-2032) & (Tons) Figure 34. Europe Endocrine Therapy Drugs (ETDs) Sales Market Share by Country (2021-2032) Figure 35. Germany Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2021-2032) & (Tons) Figure 36. France Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2021-2032) & (Tons) Figure 37. U.K. Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2021-2032) & (Tons) Figure 38. Italy Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2021-2032) & (Tons) Figure 39. Netherlands Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2021-2032) & (Tons) Figure 40. Asia Pacific Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2021-2032) & (Tons) Figure 41. Asia Pacific Endocrine Therapy Drugs (ETDs) Sales Market Share by Country (2021-2032) Figure 42. China Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2021-2032) & (Tons) Figure 43. Japan Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2021-2032) & (Tons) Figure 44. South Korea Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2021-2032) & (Tons) Figure 45. Southeast Asia Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2021-2032) & (Tons) Figure 46. India Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2021-2032) & (Tons) Figure 47. Australia Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2021-2032) & (Tons) Figure 48. South America, Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2021-2032) & (Tons) Figure 49. South America, Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales Market Share by Country (2021-2032) Figure 50. Brazil Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2021-2032) & (Tons) Figure 51. South Africa Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2021-2032) & (Tons) Figure 52. Saudi Arabia Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2021-2032) & (Tons) Figure 53. Turkey Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2021-2032) & (Tons) Figure 54. Argentina Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2021-2032) & (Tons) Figure 55. UAE Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2021-2032) & (Tons) Figure 56. Egypt Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2021-2032) & (Tons) Figure 57. Chile Endocrine Therapy Drugs (ETDs) Sales and Growth Rate (2021-2032) & (Tons) Figure 58. Global Endocrine Therapy Drugs (ETDs) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Figure 61. North America Endocrine Therapy Drugs (ETDs) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Figure 63. Europe Endocrine Therapy Drugs (ETDs) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Endocrine Therapy Drugs (ETDs) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Endocrine Therapy Drugs (ETDs) Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Endocrine Therapy Drugs (ETDs) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Endocrine Therapy Drugs (ETDs) Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Endocrine Therapy Drugs (ETDs) Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Antidiabetic Drugs
  • Anti-osteoporosis Drugs
  • Contraceptive
  • Other
Applications
  • Diabetes Treatment
  • Osteoporosis Treatment
  • Contraception
  • Other
Companies covered
  • Sanofi
  • Pfizer
  • Bayer
  • AstraZeneca
  • Tonghua Dongbao Pharmaceutical
  • Novo Nordisk
  • MSD
  • Huadong Medicine
  • Generex Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Endocrine Therapy Drugs (ETDs) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Endocrine Therapy Drugs (ETDs) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Endocrine Therapy Drugs (ETDs) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Endocrine Therapy Drugs (ETDs) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Endocrine Therapy Drugs (ETDs) Market Dynamics
  1. 2.1 Endocrine Therapy Drugs (ETDs) Industry Trends
  2. 2.2 Endocrine Therapy Drugs (ETDs) Industry Drivers
  3. 2.3 Endocrine Therapy Drugs (ETDs) Industry Opportunities and Challenges
  4. 2.4 Endocrine Therapy Drugs (ETDs) Industry Restraints
3 Endocrine Therapy Drugs (ETDs) Market by Manufacturers
  1. 3.1 Global Endocrine Therapy Drugs (ETDs) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Endocrine Therapy Drugs (ETDs) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Endocrine Therapy Drugs (ETDs) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Endocrine Therapy Drugs (ETDs) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Endocrine Therapy Drugs (ETDs) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Endocrine Therapy Drugs (ETDs) Manufacturers, Product Type & Application
  7. 3.7 Global Endocrine Therapy Drugs (ETDs) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Endocrine Therapy Drugs (ETDs) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Endocrine Therapy Drugs (ETDs) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Endocrine Therapy Drugs (ETDs) Tier 1, Tier 2, and Tier 3
4 Endocrine Therapy Drugs (ETDs) Market by Type
  1. 4.1 Endocrine Therapy Drugs (ETDs) Type Introduction
  2. 4.1.1 Antidiabetic Drugs
  3. 4.1.2 Anti-osteoporosis Drugs
  4. 4.1.3 Contraceptive
  5. 4.1.4 Other
  6. 4.2 Global Endocrine Therapy Drugs (ETDs) Sales by Type
  7. 4.2.1 Global Endocrine Therapy Drugs (ETDs) Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Endocrine Therapy Drugs (ETDs) Sales by Type (2021-2032)
  9. 4.2.3 Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Type (2021-2032)
  10. 4.3 Global Endocrine Therapy Drugs (ETDs) Revenue by Type
  11. 4.3.1 Global Endocrine Therapy Drugs (ETDs) Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Endocrine Therapy Drugs (ETDs) Revenue by Type (2021-2032)
  13. 4.3.3 Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Type (2021-2032)
5 Endocrine Therapy Drugs (ETDs) Market by Application
  1. 5.1 Endocrine Therapy Drugs (ETDs) Application Introduction
  2. 5.1.1 Diabetes Treatment
  3. 5.1.2 Osteoporosis Treatment
  4. 5.1.3 Contraception
  5. 5.1.4 Other
  6. 5.2 Global Endocrine Therapy Drugs (ETDs) Sales by Application
  7. 5.2.1 Global Endocrine Therapy Drugs (ETDs) Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Endocrine Therapy Drugs (ETDs) Sales by Application (2021-2032)
  9. 5.2.3 Global Endocrine Therapy Drugs (ETDs) Sales Market Share by Application (2021-2032)
  10. 5.3 Global Endocrine Therapy Drugs (ETDs) Revenue by Application
  11. 5.3.1 Global Endocrine Therapy Drugs (ETDs) Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Endocrine Therapy Drugs (ETDs) Revenue by Application (2021-2032)
  13. 5.3.3 Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Application (2021-2032)
6 Global Endocrine Therapy Drugs (ETDs) Sales by Region
  1. 6.1 Global Endocrine Therapy Drugs (ETDs) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Endocrine Therapy Drugs (ETDs) Sales by Region (2021-2032)
  3. 6.2.1 Global Endocrine Therapy Drugs (ETDs) Sales by Region (2021-2026)
  4. 6.2.2 Global Endocrine Therapy Drugs (ETDs) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Endocrine Therapy Drugs (ETDs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Endocrine Therapy Drugs (ETDs) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Endocrine Therapy Drugs (ETDs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Endocrine Therapy Drugs (ETDs) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Endocrine Therapy Drugs (ETDs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Endocrine Therapy Drugs (ETDs) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Endocrine Therapy Drugs (ETDs) Revenue by Region
  1. 7.1 Global Endocrine Therapy Drugs (ETDs) Revenue by Region
  2. 7.1.1 Global Endocrine Therapy Drugs (ETDs) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Endocrine Therapy Drugs (ETDs) Revenue by Region (2021-2026)
  4. 7.1.3 Global Endocrine Therapy Drugs (ETDs) Revenue by Region (2027-2032)
  5. 7.1.4 Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Endocrine Therapy Drugs (ETDs) Revenue (2021-2032)
  8. 7.2.2 North America Endocrine Therapy Drugs (ETDs) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Endocrine Therapy Drugs (ETDs) Revenue (2021-2032)
  11. 7.3.2 Europe Endocrine Therapy Drugs (ETDs) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Endocrine Therapy Drugs (ETDs) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Endocrine Therapy Drugs (ETDs) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Endocrine Therapy Drugs (ETDs) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Endocrine Therapy Drugs (ETDs) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Endocrine Therapy Drugs (ETDs) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Endocrine Therapy Drugs (ETDs) Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Endocrine Therapy Drugs (ETDs) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Endocrine Therapy Drugs (ETDs) Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Bayer
  14. 8.3.1 Bayer Company Information
  15. 8.3.2 Bayer Business Overview
  16. 8.3.3 Bayer Endocrine Therapy Drugs (ETDs) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bayer Endocrine Therapy Drugs (ETDs) Product Portfolio
  18. 8.3.5 Bayer Recent Developments
  19. 8.4 AstraZeneca
  20. 8.4.1 AstraZeneca Company Information
  21. 8.4.2 AstraZeneca Business Overview
  22. 8.4.3 AstraZeneca Endocrine Therapy Drugs (ETDs) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AstraZeneca Endocrine Therapy Drugs (ETDs) Product Portfolio
  24. 8.4.5 AstraZeneca Recent Developments
  25. 8.5 Tonghua Dongbao Pharmaceutical
  26. 8.5.1 Tonghua Dongbao Pharmaceutical Company Information
  27. 8.5.2 Tonghua Dongbao Pharmaceutical Business Overview
  28. 8.5.3 Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Product Portfolio
  30. 8.5.5 Tonghua Dongbao Pharmaceutical Recent Developments
  31. 8.6 Novo Nordisk
  32. 8.6.1 Novo Nordisk Company Information
  33. 8.6.2 Novo Nordisk Business Overview
  34. 8.6.3 Novo Nordisk Endocrine Therapy Drugs (ETDs) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Novo Nordisk Endocrine Therapy Drugs (ETDs) Product Portfolio
  36. 8.6.5 Novo Nordisk Recent Developments
  37. 8.7 MSD
  38. 8.7.1 MSD Company Information
  39. 8.7.2 MSD Business Overview
  40. 8.7.3 MSD Endocrine Therapy Drugs (ETDs) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 MSD Endocrine Therapy Drugs (ETDs) Product Portfolio
  42. 8.7.5 MSD Recent Developments
  43. 8.8 Huadong Medicine
  44. 8.8.1 Huadong Medicine Company Information
  45. 8.8.2 Huadong Medicine Business Overview
  46. 8.8.3 Huadong Medicine Endocrine Therapy Drugs (ETDs) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Huadong Medicine Endocrine Therapy Drugs (ETDs) Product Portfolio
  48. 8.8.5 Huadong Medicine Recent Developments
  49. 8.9 Generex Biotechnology
  50. 8.9.1 Generex Biotechnology Company Information
  51. 8.9.2 Generex Biotechnology Business Overview
  52. 8.9.3 Generex Biotechnology Endocrine Therapy Drugs (ETDs) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Generex Biotechnology Endocrine Therapy Drugs (ETDs) Product Portfolio
  54. 8.9.5 Generex Biotechnology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Endocrine Therapy Drugs (ETDs) Value Chain Analysis
  2. 9.1.1 Endocrine Therapy Drugs (ETDs) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Endocrine Therapy Drugs (ETDs) Production Mode & Process
  6. 9.2 Endocrine Therapy Drugs (ETDs) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Endocrine Therapy Drugs (ETDs) Distributors
  9. 9.2.3 Endocrine Therapy Drugs (ETDs) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst